» Articles » PMID: 1705032

Anti-reovirus Receptor Antibody Accelerates Expression of the Optic Nerve Oligodendrocyte Developmental Program

Overview
Specialty Science
Date 1991 Feb 15
PMID 1705032
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies showed that the cell-surface receptor for reovirus serotype 3 (Reo3R) appears at an early stage of oligodendrocyte differentiation and that anti-Reo3R antibodies and Reo3R-binding peptides induce galactocerebroside expression by developing oligodendrocytes. In the present studies, anti-Reo3R antibodies are shown to stimulate additional features of the program of oligodendrocyte development, including the loss of the A2B5 marker and expression of myelin basic protein. In anti-Reo3R antibody-treated cultures, galactocerebroside was expressed by cells having the morphology of immature oligodendrocyte precursors. Reo3R binding did not appear directly to inhibit or stimulate proliferation of glial progenitor cells or to affect their lineage commitment. Cell-surface structures utilized as a receptor by reovirus type 3 appear to play a role in the regulation of the initiation or rate of execution of the oligodendrocyte developmental program.

Citing Articles

Do Antibodies Stimulate Myelin Repair in Multiple Sclerosis?.

McGavern D, Asakura K, Rodriquez M Neuroscientist. 2019; 5(1):19-28.

PMID: 31118550 PMC: 6527372. DOI: 10.1177/107385849900500104.


Structure based antibody-like peptidomimetics.

Murali R, Greene M Pharmaceuticals (Basel). 2013; 5(2):209-35.

PMID: 24288089 PMC: 3763629. DOI: 10.3390/ph5020209.


Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.

Warrington A, Asakura K, Bieber A, Ciric B, Van Keulen V, Kaveri S Proc Natl Acad Sci U S A. 2000; 97(12):6820-5.

PMID: 10841576 PMC: 18751. DOI: 10.1073/pnas.97.12.6820.


Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.

Pavelko K, van Engelen B, Rodriguez M J Neurosci. 1998; 18(7):2498-505.

PMID: 9502810 PMC: 6793082.

References
1.
Cohen J, Sergott R, Geller H, Brown M, Greene M . Mammalian reovirus receptor expression by oligodendrocytes. Ann N Y Acad Sci. 1988; 540:445-8. DOI: 10.1111/j.1749-6632.1988.tb27129.x. View

2.
Williams W, Moss D, Kieber-Emmons T, Cohen J, Myers J, Weiner D . Development of biologically active peptides based on antibody structure. Proc Natl Acad Sci U S A. 1989; 86(14):5537-41. PMC: 297658. DOI: 10.1073/pnas.86.14.5537. View

3.
Gaulton G, Greene M . Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody. J Exp Med. 1989; 169(1):197-211. PMC: 2189184. DOI: 10.1084/jem.169.1.197. View

4.
Co M, Gaulton G, Tominaga A, Homcy C, Fields B, Greene M . Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A. 1985; 82(16):5315-8. PMC: 390558. DOI: 10.1073/pnas.82.16.5315. View

5.
Co M, Gaulton G, Fields B, Greene M . Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A. 1985; 82(5):1494-8. PMC: 397289. DOI: 10.1073/pnas.82.5.1494. View